TY - JOUR
T1 - Oral d-amphetamine and ketamine self-administration by rhesus monkeys
T2 - Effects of food deprivation
AU - Carroll, M. E.
AU - Stotz, D. C.
PY - 1983
Y1 - 1983
N2 - Orally delivered d-amphetamine and ketamine were tested for their ability to maintain self-administration behavior by substituting them for phencyclidine. Six monkeys were trained to self-administer phencyclidine (0.25 mg/ml) and water under a concurrent fixed-ratio 16 schedule during 3-hr sessions. At the start of the experiment the monkeys were maintained at 85% of their free-feeding body weights. Liquid deliveries were contingent upon lip-contact responses on solenoid-operated drinking spouts. When d-amphetamine (0.0156-0.25 mg/ml) was substituted for phencyclidine, maximum drug intake ranged from 1 to 1.5 mg/kg among three monkeys, and response rates were greatest at the three lower concentrations (0.0156-0.0625 mg/ml). When monkeys were food satiated, maximum d-amphetamine intake ranged from 0.3 to 1.1 mg/kg among three monkeys, and response rates were greatest at the higher concentrations (0.125-0.25 mg/ml). In the second experiment, ketamine (0.125-4 mg/ml) was substituted for phencyclidine (0.25 mg/ml). Maximum ketamine intake ranged from 14.5 to 44.5 mg/kg among three monkeys, and maximum responding occurred at the 0.25- and 1-mg/ml concentrations. Food satiation reduced maximum ketamine intake (7.1-22.3 mg/kg) among three monkeys. With both d-amphetamine and ketamine, responding was evenly distributed throughout the session during food satiation, whereas during food deprivation, most responding occurred within the 1st hr of the session. These results showed that substitution procedures can be effectively used to demonstrate the reinforcing effects of orally delivered d-amphetamine and ketamine. Food deprivation generally increased drug-reinforced responding; however, at the higher concentrations of drug this difference was greatly diminished. Thus, the magnitude of the food deprivation effect was greatly altered by changes in drug concentration.
AB - Orally delivered d-amphetamine and ketamine were tested for their ability to maintain self-administration behavior by substituting them for phencyclidine. Six monkeys were trained to self-administer phencyclidine (0.25 mg/ml) and water under a concurrent fixed-ratio 16 schedule during 3-hr sessions. At the start of the experiment the monkeys were maintained at 85% of their free-feeding body weights. Liquid deliveries were contingent upon lip-contact responses on solenoid-operated drinking spouts. When d-amphetamine (0.0156-0.25 mg/ml) was substituted for phencyclidine, maximum drug intake ranged from 1 to 1.5 mg/kg among three monkeys, and response rates were greatest at the three lower concentrations (0.0156-0.0625 mg/ml). When monkeys were food satiated, maximum d-amphetamine intake ranged from 0.3 to 1.1 mg/kg among three monkeys, and response rates were greatest at the higher concentrations (0.125-0.25 mg/ml). In the second experiment, ketamine (0.125-4 mg/ml) was substituted for phencyclidine (0.25 mg/ml). Maximum ketamine intake ranged from 14.5 to 44.5 mg/kg among three monkeys, and maximum responding occurred at the 0.25- and 1-mg/ml concentrations. Food satiation reduced maximum ketamine intake (7.1-22.3 mg/kg) among three monkeys. With both d-amphetamine and ketamine, responding was evenly distributed throughout the session during food satiation, whereas during food deprivation, most responding occurred within the 1st hr of the session. These results showed that substitution procedures can be effectively used to demonstrate the reinforcing effects of orally delivered d-amphetamine and ketamine. Food deprivation generally increased drug-reinforced responding; however, at the higher concentrations of drug this difference was greatly diminished. Thus, the magnitude of the food deprivation effect was greatly altered by changes in drug concentration.
UR - http://www.scopus.com/inward/record.url?scp=0021063060&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021063060&partnerID=8YFLogxK
M3 - Article
C2 - 6684685
AN - SCOPUS:0021063060
SN - 0022-3565
VL - 227
SP - 28
EP - 34
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 1
ER -